Medtronic Aktie News

Medtronic exceeds fiscal second-quarter earnings and revenue expectations.

Medical device maker Medtronic topped Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by strong demand for its heart disease and diabetes devices.

Cardiac Ablation Solutions growth of 71% on strength of pulsed field ablation (PFA) portfolio; Raising FY26 revenue and EPS guidance GALWAY, Ireland , Nov. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its second quarter (Q2) of fiscal year 2026 (FY26), which ended October 24, 2025. Q2 Key Highlights Revenue o...

Medical device maker Medtronic boasts an attractive yield and a long history of dividend growth. Pfizer is demonstrating its ability to make the necessary moves to rebuild its drug pipeline.

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

Coca-Cola is a Dividend King beverage giant with a reasonable valuation. Enbridge is a North American midstream giant with 30 annual dividend increases under its belt.

ANTWERP, Belgium--(BUSINESS WIRE)--Minze Health partners with Medtronic to integrate its automated bladder diary, Minze Diary Pod, into Sacral Neuromodulation care for OAB patients.

Medtronic plc offers stable dividends and consistent cash flow, but growth remains lackluster with revenues plateauing and limited expansion prospects. MDT's product pipeline, especially in cardiovascular health and diabetes, shows promise but is unlikely to significantly accelerate overall revenue or EPS growth. Shares are not attractively valued for growth investors, with a low risk profile b...